The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 307.00
Ask: 312.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.629%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 310.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Thu, 29th Apr 2021 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

STV Group PLC - Glasgow-based television broadcaster - Says recovery of advertising revenue exceeds expectations, running 10% ahead of forecasts. "STV-controlled advertising continues to outperform the wider market, with regional advertising revenues up 12% in the first four months of the year," company adds. Video on demand service advertising also grew, up 26% annually and posts eight successive months of growth. Online viewing grew 73% in first quarter. Expects viewing figures in June as delayed Euro 2020 football championships kick off.

----------

In The Style Group PLC - e-commerce womenswear fashion brand - Says sales momentum since March float top expectations. Revenue for year ended March 31 to soar to GBP44.5 million from GBP19.3 million. "In light of the strong trading performance, prior to the year end the group returned financial support previously claimed under the Coronavirus Job Retention Scheme," company adds.

----------

Inspecs Group PLC - eyewear design house and manufacturer based in Bath - Says first quarter revenue amounted to USD67 million. "This performance was achieved despite nationwide lockdowns in the UK, Germany and France and a variety of state lockdowns in the USA," Inspecs says. "Whilst this performance marks a positive start to the year, the board remains cautious on 2021 as Covid-19 remains prevalent across the world."

----------

Appreciate Group PLC - Liverpool-based multi-retailer - Pretax profit for year ended March 31 in line with market expectations range of GBP4.1 million an GBP4.8 million. Group billings down 3.2% to GBP406.5 million from GBP419.9 million.

----------

City Pub Group PLC - operates 48 pubs in southern England and Wales - Acquires 49% stake in Barts Pub Ltd, owner of Kensington Park Hotel in London's Ladbroke Grove, for GBP750,000. "It has large trading areas on the ground and first floors, benefits from seven hotel letting rooms and has potential for a further four letting rooms on the top floor. Ladbroke Grove is a prime residential area in London and the Company trades very successfully at the Cock & Bottle, Notting Hill, which is located close by," City Pub says. Increases stake in Mosaic Pub & Dining Group to 24% for GBP1.2 million. "The company acquired a 14% stake in the Mosaic Companies in September 2020 and this transaction takes its total investment to GBP2.4 million," company adds. Mosaic owns nine "prominent pubs" and largely operates in London and Birmingham.

----------

Arricano Real Estate PLC - developer and shopping mall operator in Ukraine - In separate announcements notes the easing of restrictions in Ukraine and an altered loan facility in country. Says Kiev retail shopping centres to reopen on May 1 but says its City Mall in Zaporizhzhia closed until further notice. Also says unit LLC Comfort Market Luks alters debt arrangement with State Savings Bank of Ukraine. Debt now carries 6.5% annual interest, down from 7.5%.

-----------

Symphony International Holdings Ltd - Hong Kong-based investor - Asset Value Investors, which holds 15% stake in Symphony, takes aim at management of investment firm. Pens note to shareholders labelled "Save Symphony". "The poor performance of Symphony International Holdings Ltd has gone on long enough. We have two key aims and we need the support of our fellow shareholders to make them a reality," Asset Value Executive Director Tom Treanor says. Company wants to gather enough support to requisition extraordinary general meeting to replace directors. Also wants all shareholders to be "fully informed as to our concerns regarding the stewardship of SIHL and the independence of the board".

----------

LMS Capital PLC - London-based investment firm - Net asset value at end of first quarter slips 0.8% to 58.9 pence per share from 59.4p at end of December. Sees GBP300,000 unrealised gains on investment portfolio, but GBP200,000 million foreign exchange hit and GBP500,000 of running and investment costs.

----------

FastForward Innovations Ltd - investor in life sciences and technology businesses particularly within the medical cannabis field - Says 5.1%-owned Yooma Wellness Inc's CBD food products from its MYO Plant Nutrition and Blossom brands added to UK Food Standard Agency's novel foods list. "This approval represents a significant milestone for the MYO and Blossom brands," Yooma Chair Lorne Abony says.

----------

Hutchison China Meditech Ltd - Hong-Kong-based pharmaceutical company - Initiates registration-intent Phase II clinical trial of HMPL‑689, a PI3Ko inhibitor and can be used to treat forms of cancer. Trial focused on patients with relapsed or refractory follicular lymphoma and marginal zone lymphoma. On Wednesday, shareholders backed company's name change to Hutchmed (China) Ltd. Name change effective only Registrar of Companies issues certificate.

----------

Verici Dx PLC - clinical diagnostics developer for organ transplant - Signs lease in Tennessee, US for site it plans to use as Clinical Laboratory Improvement Amendments-certified laboratory. "I joined the company in January this year to help expedite the CLIA approval strategy and signing the lease to this space marks the first step towards achieving these CLIA approvals necessary for commercial launch of the company's leading products, Clarava and Tuteva," Vice President of Quality & Regulatory Affairs David Schultenover says.

----------

InnovaDerma PLC - London-based developer of beauty, personal care and life science products - Raises GBP500,000 from open offer, taking total fundraising to GBP4.5 million. Non-Executive Chair Ross Andrews says "macroeconomic environment is set to remain uncertain" this financial year but notes UK vaccinations and government lockdown easing roadmap going according to plan. "We've just entered the peak tanning season and the exact speed of a return to historical consumption levels will only be known over the coming months," Andrews adds.

----------

Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Says revenue for year ended March 31 to rise 10% to GBP18.3 million from GBP16.6 million. "This is in line with recently issued guidance and reflects strong performances for European core revenues and for Covid-related testing products and services focused on the UK, more than offsetting the pandemic headwinds affecting international sales," Yourgene adds.

----------

Silence Therapeutics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says first patient dosed in Gemini Phase I clinical trial of SLN124, a treatment for a rare pediatric disease. "Today's announcement is an exciting milestone in the development of SLN124. It is the result of many years of hard work," Chief Medical Officer Giles Campion says.

----------

Danakali Ltd - Colluli potash project developer - Raises AUD20.3 million, to fund work at Colluli asset, Eritrea. Says early works programme will begin "immediately".

----------

Greatland Gold PLC - precious and base metals exploration and development in Western Australia and Tasmania - Notes Newcrest Mining Ltd's quarterly update which refers to progress at Havieron gold asset. Says new assay results show four holes intersect "significant mineralisation". Results from wider growth drilling "continue to support the potential for resource expansion of the Havieron".

----------

Salt Lake Potash Ltd - Western Australia focused organic sulphate of potash miner - Receives new portion of environmental approval for Lake Way project. Says permit enables firm to construct pond trains 4-6. "Receiving final environmental approval over the full Lake Way project will enable our team to commence construction of the remaining on-lake infrastructure and deliver the full scope of the Lake Way project. We look forward to commencing work shortly on this final phase," Chief Executive Officer Tony Swiericzuk says.

----------

Ariana Resources PLC - exploration and development company operating in Europe - Reports promising findings from drilling results at Arzu North portion of Kiziltepe mine in Turkey. Says over 450 metres of "potentially open-pittable extensions confirmed". Adds that revised JORC exploration target now includes addition 7,000 ounces to 25,000 ounces of gold and 150,000 ounces to 250,000 ounces of silver, representing a more than four-fold resource hike. "This is an excellent set of results from the recent drilling at Arzu North. Collectively these results confirm the potential to extend the Arzu North open pit both to the northwest and to the southeast," Managing Director Kerim Sener says.

----------

Condor Gold PLC - gold exploration and development in Nicaragua - Says all infill drilling and assay at La India starter pits completed. "The drilling results received to date support, and add considerable confidence to, the geological model," Condor Gold says. Drilling underway for remaining 1,142 metres of work in La India open pit shell.

----------

Horizonte Minerals PLC - nickel company focused on Brazil - Hands environmental & social impact assessment at Vermelho nickel and cobalt project to consultancy firm Ramboll. "Ramboll's Impact Assessment services are based on both commercial understanding and technical rigour to deliver projects that are advanced, sustainable and provide value to society. Horizonte has previously worked with Ramboll on the hydrology for its flagship Araguaia ferronickel project," Horizonte adds.

----------

Gaming Realms PLC - London-based mobile games developer - Begins trading on OTCQX Best Market in US. "Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors," company notes.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Jul 2022 13:20

IN BRIEF: Hutchmed starts phase I trial of HMPL-A83

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Begins phase I trial of HMPL-A83 for patients with advanced malignant neoplasms, in China. HMPL-A83 is an investigational novel IgG4-type humanized anti-CD47 monoclonal antibody. Malignant neoplasms are cancerous tumours. It has "significant" potential to be used as a combination therapy with Hutchmed's existing portfolio, the firm says.

Read more
13 Jul 2022 09:35

IN BRIEF: Hutchmed presents solid results from lung cancer study

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Presents positive results from the Savannah phase two trial of Hutchmed and AstraZeneca PLC's savolitinib in combination with Astra's osimertinib in epidermal growth factor receptor-mutated non-small cell lung cancer patients.

Read more
6 Jul 2022 10:37

AIM WINNERS & LOSERS: Hutchmed down amid China Covid woes; Parkmead up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
6 Jul 2022 09:25

Hutchmed phase I trial for IMG-007 doses first patient

(Alliance News) - Hutchmed China Ltd on Wednesday announced the first patient has been dosed for its phase I trial for IMG-007.

Read more
1 Jun 2022 10:07

IN BRIEF: Hutchmed China wins cancer drug Tazverik approval in Hainan

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Receives approval for Tazverik from the Health Commission & Medical Products Administration of the Hainan province in China. The approval is for use in the Hainan pilot zone under the Clinically Urgently Needed Imported Drugs scheme, for the treatment of certain patients with epithelioid sarcoma and follicular lymphoma.

Read more
3 May 2022 12:14

LONDON MARKET MIDDAY: Stocks down as aggressive US Fed rate hike looms

(Alliance News) - Stock prices in London were lower at midday on Tuesday following the long bank holiday weekend in the UK, as markets globally prepare for a sharp US interest rate hike and similar moves by other central banks as they struggle to control inflation.

Read more
3 May 2022 11:29

AIM WINNERS & LOSERS: Hutchmed sinks on US FDA drug rejection

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
3 May 2022 11:25

IN BRIEF: US FDA says Hutchmed's pancreatic drug needs more testing

Hutchmed (China) Ltd - Hong Kong-based biopharmaceuticals - The US Food & Drug Administration has rejected Hutchmed's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA says the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively. Chief Executive Officer & Chief Scientific Officer Weiguo Su comments: "Although this decision from the FDA is disappointing, we remain confident about the clinical value of surufatinib for NET patients and committed to making surufatinib available to patients globally. We look forward to working with the agency to evaluate its feedback."

Read more
3 May 2022 08:57

LONDON MARKET OPEN: BP rises despite taking hit from Rosneft exit

(Alliance News) - Stock prices in London opened lower on Tuesday following the long bank holiday weekend, with BP shares rising as the oil major planned to return cash to shareholders amid calls by some UK politicians for a windfall profit tax on energy companies.

Read more
3 May 2022 07:53

LONDON MARKET PRE-OPEN: BP swings to quarterly loss after Rosneft exit

(Alliance News) - Stock prices in London are seen opening lower on Tuesday, after the long bank holiday weekend in the UK, as concerns rise over aggressive monetary policy tightening by the US Federal Reserve.

Read more
25 Apr 2022 10:45

AIM WINNERS & LOSERS: musicMagpie sells on new platform; Hutchmed down

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Apr 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 21 April 
Alliance Trust PLCAGM
Ibstock PLCAGM
Journeo PLCAGM
Relx PLCAGM
STV Group PLCAGM
Ruffer Investment Co LtdEGM re share issue
Friday 22 April 
Bellevue Healthcare Trust PLCAGM
Faron Pharmaceuticals LtdAGM
Murray International Trust PLCAGM
Monday 25 April 
Belluscura PLCAGM
Capital Gearing Trust PLCGM re non pre-emptive share issue
Cloudbreak Discovery PLCGM re Crescita equity drawdown agreement
Hikma Pharmaceuticals PLCAGM
JPMorgan US Smaller Cos Investment Trust PLCAGM
Polymetal International PLCAGM
Symphony International Holdings LtdAGM
Tuesday 26 April 
Aquis Exchange PLCAGM
Elementis PLCAGM
GlobalData PLCAGM
Oriole Resources PLCAGM
RPS Group PLCAGM
SigmaRoc PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Wednesday 27 April 
Drax Group PLCAGM
EP Global Opportunities Trust PLCAGM
Global Invacom Group LtdAGM
Hutchmed (China) LtdAGM
London Stock Exchange Group PLCAGM
McKay Securities PLCGM re Workspace offer
Nichols PLCAGM
Persimmon PLCAGM
Primary Health Properties PLCAGM
VH Global Sustainable Energy Opportunities PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
31 Mar 2022 10:43

IN BRIEF: Hutchmed China named by SEC, might delist Nasdaq shares

Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - US Securities & Exchange Commission identifies Hutchmed China under the new Holding Foreign Companies Accountable Act, which identifies public companies who have used auditors from overseas or auditors who are unable to be investigated completely. The new regulation has no impact on business operations, Hutchmed says.

Read more
31 Mar 2022 10:04

Hutchmed China confident after being added to SEC list

(Sharecast News) - Hutchmed China updated the market on its status under the United States 'Holding Foreign Companies Accountable Act' on Thursday.

Read more
11 Mar 2022 11:15

AIM WINNERS & LOSERS: Omega Diagnostics Visitect not available in UK

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.